Human chest wall function while awake and during halothane anesthesia

II. Carbon dioxide rebreathing

David Oman Warner, M. A. Warner

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Changes in the distribution of respiratory drive to different respiratory muscles may contribute to respiratory depression produced by halothane. The aim of this study was to examine factors that are responsible for halothane-induced depression of the ventilatory response to carbon dioxide rebreathing. Methods: In six human subjects, respiratory muscle activity in the parasternal intercostal, abdominal, and diaphragm muscles was measured using fine-wire electromyography electrodes. Chest wall motion was determined by respiratory impedance plethysmography. Electromyography activities and chest wall motion were measured during hyperpnea produced by carbon dioxide rebreathing while the subjects were awake and during 1 MAC halothane anesthesia. Results: Halothane anesthesia significantly reduced the slope of the response of expiratory minute ventilation to carbon dioxide (from 2.88 ± 0.73 (mean ± SE) to 2.01 ± 0.45 l · min-1 · mmHg-1). During the rebreathing period, breathing frequency significantly increased while awake (from 10.3 ± 1.4 to 19.7 + 2.6 min1, P < 0.05) and significantly decreased while anesthetized (from 28.8 ± 3.9 to 21.7 ± 1.9 min-1, P < 0.05). Increases in respiratory drive to the phrenic motoneutons produced by rebreathing, as estimated by the diaphragm electromyogram, were enhanced by anesthesia. Anesthesia attenuated the response of parasternal electromyography and accentuated the response of the transversus abdominis electromyography to rebreathing. The compartmental response of the ribcage to rebreathing was significantly decreased by anesthesia (from 1.83 ± 0.58 to 0.48 + 0.131 · min-1 · mmHg-1), and marked phase shifts between ribcage and abdominal motion developed in some subjects. However, at comparable tidal volumes, the ribcage contribution to ventilation was similar while awake and anesthetized in four of the six subjects. Conclusions: Halothane anesthesia enhances the rebreathing response of neural drive to the primary respiratory muscle, the diaphragm. These findings provide direct evidence that, at the dose examined in this study, halothane-induced respiratory depression is caused by alterations in the distribution and timing of neural drive to the respiratory muscles, rather than a global depression of respiratory motoneuron drive.

Original languageEnglish (US)
Pages (from-to)20-31
Number of pages12
JournalAnesthesiology
Volume82
Issue number1
DOIs
StatePublished - 1995

Fingerprint

Thoracic Wall
Halothane
Carbon Dioxide
Electromyography
Respiratory Muscles
Anesthesia
Diaphragm
Respiratory Insufficiency
Abdominal Muscles
Ventilation
Closed-Circuit Anesthesia
Impedance Plethysmography
Tidal Volume
Motor Neurons
Electrodes
Respiration
Rib Cage

Keywords

  • Anesthetics, volatile: halothane
  • Lung: breathing pattern; diaphragm; functional residual capacity; intrathoracic blood volume; ribcage
  • Measurement technique: electromyography; respiratory impedance plethysmography
  • Muscle: diaphragm; external oblique; parasternal intercostal; respiratory; transversus abdominis

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Human chest wall function while awake and during halothane anesthesia : II. Carbon dioxide rebreathing. / Warner, David Oman; Warner, M. A.

In: Anesthesiology, Vol. 82, No. 1, 1995, p. 20-31.

Research output: Contribution to journalArticle

@article{e49f35d9e17a4874a5f65fa323329e24,
title = "Human chest wall function while awake and during halothane anesthesia: II. Carbon dioxide rebreathing",
abstract = "Background: Changes in the distribution of respiratory drive to different respiratory muscles may contribute to respiratory depression produced by halothane. The aim of this study was to examine factors that are responsible for halothane-induced depression of the ventilatory response to carbon dioxide rebreathing. Methods: In six human subjects, respiratory muscle activity in the parasternal intercostal, abdominal, and diaphragm muscles was measured using fine-wire electromyography electrodes. Chest wall motion was determined by respiratory impedance plethysmography. Electromyography activities and chest wall motion were measured during hyperpnea produced by carbon dioxide rebreathing while the subjects were awake and during 1 MAC halothane anesthesia. Results: Halothane anesthesia significantly reduced the slope of the response of expiratory minute ventilation to carbon dioxide (from 2.88 ± 0.73 (mean ± SE) to 2.01 ± 0.45 l · min-1 · mmHg-1). During the rebreathing period, breathing frequency significantly increased while awake (from 10.3 ± 1.4 to 19.7 + 2.6 min1, P < 0.05) and significantly decreased while anesthetized (from 28.8 ± 3.9 to 21.7 ± 1.9 min-1, P < 0.05). Increases in respiratory drive to the phrenic motoneutons produced by rebreathing, as estimated by the diaphragm electromyogram, were enhanced by anesthesia. Anesthesia attenuated the response of parasternal electromyography and accentuated the response of the transversus abdominis electromyography to rebreathing. The compartmental response of the ribcage to rebreathing was significantly decreased by anesthesia (from 1.83 ± 0.58 to 0.48 + 0.131 · min-1 · mmHg-1), and marked phase shifts between ribcage and abdominal motion developed in some subjects. However, at comparable tidal volumes, the ribcage contribution to ventilation was similar while awake and anesthetized in four of the six subjects. Conclusions: Halothane anesthesia enhances the rebreathing response of neural drive to the primary respiratory muscle, the diaphragm. These findings provide direct evidence that, at the dose examined in this study, halothane-induced respiratory depression is caused by alterations in the distribution and timing of neural drive to the respiratory muscles, rather than a global depression of respiratory motoneuron drive.",
keywords = "Anesthetics, volatile: halothane, Lung: breathing pattern; diaphragm; functional residual capacity; intrathoracic blood volume; ribcage, Measurement technique: electromyography; respiratory impedance plethysmography, Muscle: diaphragm; external oblique; parasternal intercostal; respiratory; transversus abdominis",
author = "Warner, {David Oman} and Warner, {M. A.}",
year = "1995",
doi = "10.1097/00000542-199501000-00004",
language = "English (US)",
volume = "82",
pages = "20--31",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Human chest wall function while awake and during halothane anesthesia

T2 - II. Carbon dioxide rebreathing

AU - Warner, David Oman

AU - Warner, M. A.

PY - 1995

Y1 - 1995

N2 - Background: Changes in the distribution of respiratory drive to different respiratory muscles may contribute to respiratory depression produced by halothane. The aim of this study was to examine factors that are responsible for halothane-induced depression of the ventilatory response to carbon dioxide rebreathing. Methods: In six human subjects, respiratory muscle activity in the parasternal intercostal, abdominal, and diaphragm muscles was measured using fine-wire electromyography electrodes. Chest wall motion was determined by respiratory impedance plethysmography. Electromyography activities and chest wall motion were measured during hyperpnea produced by carbon dioxide rebreathing while the subjects were awake and during 1 MAC halothane anesthesia. Results: Halothane anesthesia significantly reduced the slope of the response of expiratory minute ventilation to carbon dioxide (from 2.88 ± 0.73 (mean ± SE) to 2.01 ± 0.45 l · min-1 · mmHg-1). During the rebreathing period, breathing frequency significantly increased while awake (from 10.3 ± 1.4 to 19.7 + 2.6 min1, P < 0.05) and significantly decreased while anesthetized (from 28.8 ± 3.9 to 21.7 ± 1.9 min-1, P < 0.05). Increases in respiratory drive to the phrenic motoneutons produced by rebreathing, as estimated by the diaphragm electromyogram, were enhanced by anesthesia. Anesthesia attenuated the response of parasternal electromyography and accentuated the response of the transversus abdominis electromyography to rebreathing. The compartmental response of the ribcage to rebreathing was significantly decreased by anesthesia (from 1.83 ± 0.58 to 0.48 + 0.131 · min-1 · mmHg-1), and marked phase shifts between ribcage and abdominal motion developed in some subjects. However, at comparable tidal volumes, the ribcage contribution to ventilation was similar while awake and anesthetized in four of the six subjects. Conclusions: Halothane anesthesia enhances the rebreathing response of neural drive to the primary respiratory muscle, the diaphragm. These findings provide direct evidence that, at the dose examined in this study, halothane-induced respiratory depression is caused by alterations in the distribution and timing of neural drive to the respiratory muscles, rather than a global depression of respiratory motoneuron drive.

AB - Background: Changes in the distribution of respiratory drive to different respiratory muscles may contribute to respiratory depression produced by halothane. The aim of this study was to examine factors that are responsible for halothane-induced depression of the ventilatory response to carbon dioxide rebreathing. Methods: In six human subjects, respiratory muscle activity in the parasternal intercostal, abdominal, and diaphragm muscles was measured using fine-wire electromyography electrodes. Chest wall motion was determined by respiratory impedance plethysmography. Electromyography activities and chest wall motion were measured during hyperpnea produced by carbon dioxide rebreathing while the subjects were awake and during 1 MAC halothane anesthesia. Results: Halothane anesthesia significantly reduced the slope of the response of expiratory minute ventilation to carbon dioxide (from 2.88 ± 0.73 (mean ± SE) to 2.01 ± 0.45 l · min-1 · mmHg-1). During the rebreathing period, breathing frequency significantly increased while awake (from 10.3 ± 1.4 to 19.7 + 2.6 min1, P < 0.05) and significantly decreased while anesthetized (from 28.8 ± 3.9 to 21.7 ± 1.9 min-1, P < 0.05). Increases in respiratory drive to the phrenic motoneutons produced by rebreathing, as estimated by the diaphragm electromyogram, were enhanced by anesthesia. Anesthesia attenuated the response of parasternal electromyography and accentuated the response of the transversus abdominis electromyography to rebreathing. The compartmental response of the ribcage to rebreathing was significantly decreased by anesthesia (from 1.83 ± 0.58 to 0.48 + 0.131 · min-1 · mmHg-1), and marked phase shifts between ribcage and abdominal motion developed in some subjects. However, at comparable tidal volumes, the ribcage contribution to ventilation was similar while awake and anesthetized in four of the six subjects. Conclusions: Halothane anesthesia enhances the rebreathing response of neural drive to the primary respiratory muscle, the diaphragm. These findings provide direct evidence that, at the dose examined in this study, halothane-induced respiratory depression is caused by alterations in the distribution and timing of neural drive to the respiratory muscles, rather than a global depression of respiratory motoneuron drive.

KW - Anesthetics, volatile: halothane

KW - Lung: breathing pattern; diaphragm; functional residual capacity; intrathoracic blood volume; ribcage

KW - Measurement technique: electromyography; respiratory impedance plethysmography

KW - Muscle: diaphragm; external oblique; parasternal intercostal; respiratory; transversus abdominis

UR - http://www.scopus.com/inward/record.url?scp=0028814822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028814822&partnerID=8YFLogxK

U2 - 10.1097/00000542-199501000-00004

DO - 10.1097/00000542-199501000-00004

M3 - Article

VL - 82

SP - 20

EP - 31

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 1

ER -